Estriol dihexanoate: Difference between revisions
Appearance
Content deleted Content added
Hammelsmith (talk | contribs) Added free to read link in citations with OAbot #oabot |
consistent citation formatting |
||
(8 intermediate revisions by 7 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = |
| Verifiedfields = |
||
Line 28: | Line 29: | ||
<!-- Identifiers --> |
<!-- Identifiers --> |
||
| CAS_number_Ref = |
| CAS_number_Ref = {{cascite|correct|CAS}} |
||
| CAS_number = 104202-96-2 |
| CAS_number = 104202-96-2 |
||
| CAS_supplemental = |
| CAS_supplemental = |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
⚫ | |||
| ATC_prefix = |
| ATC_prefix = |
||
| ATC_suffix = |
| ATC_suffix = |
||
Line 40: | Line 43: | ||
| ChemSpiderID_Ref = |
| ChemSpiderID_Ref = |
||
| ChemSpiderID = 113906 |
| ChemSpiderID = 113906 |
||
⚫ | |||
| KEGG = |
| KEGG = |
||
| ChEBI = |
| ChEBI = |
||
Line 48: | Line 51: | ||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=30 | H=44 | O=5 |
| C=30 | H=44 | O=5 |
||
| molecular_weight = 484.677 g/mol |
|||
| SMILES = CCCCCC(=O)O[C@H]1[C@@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C3C=CC(=C4)OC(=O)CCCCC)C)O |
| SMILES = CCCCCC(=O)O[C@H]1[C@@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C3C=CC(=C4)OC(=O)CCCCC)C)O |
||
| StdInChI_Ref = |
| StdInChI_Ref = |
||
Line 56: | Line 58: | ||
}} |
}} |
||
'''Estriol dihexanoate''', or '''estriol 3,17β-dihexanoate''', is a [[synthetic compound|synthetic]] [[estrogen (medication)|estrogen]] and [[estrogen ester]] – specifically, the C3 and C17β [[hexanoate|dihexanoate]] [[ester]] of [[estriol (medication)|estriol]] – which was first described in 1963 and was never marketed.<ref name="OettelSchillinger2012">{{cite book| |
'''Estriol dihexanoate''', or '''estriol 3,17β-dihexanoate''', is a [[synthetic compound|synthetic]] [[estrogen (medication)|estrogen]] and [[estrogen ester]] – specifically, the C3 and C17β [[hexanoate|dihexanoate]] [[ester]] of [[estriol (medication)|estriol]] – which was first described in 1963 and was never marketed.<ref name="OettelSchillinger2012">{{cite book| vauthors = Kuhnz W, Blode H, Zimmermann H | chapter = Pharmacokinetics of exogenous natural and synthetic estrogens and antiestrogens| veditors = Oettel M, Schillinger E |title=Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen| chapter-url = https://books.google.com/books?id=wBvyCAAAQBAJ&pg=PA273 |date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-3-642-60107-1|pages=273–}}</ref><ref name="pmid13994597">{{cite journal | vauthors = Tsuneda K, Yamada J, Yasuda K, Mori H | title = Preparation of some estriol esters | journal = Chemical & Pharmaceutical Bulletin | volume = 11 | issue = 4 | pages = 510–514 | date = April 1963 | pmid = 13994597 | doi = 10.1248/cpb.11.510 | doi-access = free }}</ref><ref name="pmid1819548">{{cite journal | vauthors = Heithecker R, Aedo AR, Landgren BM, Cekan SZ | title = Plasma estriol levels after intramuscular injection of estriol and two of its esters | journal = Hormone Research | volume = 35 | issue = 6 | pages = 234–238 | date = 1991 | pmid = 1819548 | doi = 10.1159/000181911 }}</ref> Following a single [[intramuscular injection]] of 8.90 mg estriol dihexanoate (equivalent to 5.0 mg estriol) in an [[oil solution]], [[Cmax (pharmacology)|peak levels]] of estriol occurred after 2.1 to 3.4 days, an [[elimination half-life]] of 187 to 221 hours was observed, and estriol levels remained elevated for up to 20 to 50 days.<ref name="OettelSchillinger2012" /><ref name="pmid1819548" /> For comparison, the [[duration of action|duration]]s of estriol and [[estriol dipropionate]] were far shorter.<ref name="OettelSchillinger2012" /><ref name="pmid1819548" /> |
||
==See also== |
== See also == |
||
* [[List of estrogen esters#Estriol esters|List of estrogen esters § Estriol esters]] |
* [[List of estrogen esters#Estriol esters|List of estrogen esters § Estriol esters]] |
||
==References== |
== References == |
||
{{Reflist}} |
{{Reflist}} |
||
Line 68: | Line 70: | ||
[[Category:Abandoned drugs]] |
[[Category:Abandoned drugs]] |
||
[[Category:Caproate esters]] |
[[Category:Caproate esters]] |
||
[[Category:Estranes]] |
|||
[[Category:Estriol esters]] |
[[Category:Estriol esters]] |
||
[[Category:Prodrugs]] |
|||
[[Category:Synthetic estrogens]] |
[[Category:Synthetic estrogens]] |
||
[[Category: |
[[Category:Secondary alcohols]] |
||
{{Steroid-stub}} |
{{Steroid-stub}} |
Latest revision as of 15:58, 29 December 2023
Clinical data | |
---|---|
Other names | Oestriol dihexanoate; Estriol 3,17β-dihexanoate; 16α-Hydroxyestra-1,3,5(10)-triene-3,17β-diyl dihexanoate |
Routes of administration | Intramuscular injection |
Drug class | Estrogen; Estrogen ester |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C30H44O5 |
Molar mass | 484.677 g·mol−1 |
3D model (JSmol) | |
| |
|
Estriol dihexanoate, or estriol 3,17β-dihexanoate, is a synthetic estrogen and estrogen ester – specifically, the C3 and C17β dihexanoate ester of estriol – which was first described in 1963 and was never marketed.[1][2][3] Following a single intramuscular injection of 8.90 mg estriol dihexanoate (equivalent to 5.0 mg estriol) in an oil solution, peak levels of estriol occurred after 2.1 to 3.4 days, an elimination half-life of 187 to 221 hours was observed, and estriol levels remained elevated for up to 20 to 50 days.[1][3] For comparison, the durations of estriol and estriol dipropionate were far shorter.[1][3]
See also
[edit]References
[edit]- ^ a b c Kuhnz W, Blode H, Zimmermann H (6 December 2012). "Pharmacokinetics of exogenous natural and synthetic estrogens and antiestrogens". In Oettel M, Schillinger E (eds.). Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen. Springer Science & Business Media. pp. 273–. ISBN 978-3-642-60107-1.
- ^ Tsuneda K, Yamada J, Yasuda K, Mori H (April 1963). "Preparation of some estriol esters". Chemical & Pharmaceutical Bulletin. 11 (4): 510–514. doi:10.1248/cpb.11.510. PMID 13994597.
- ^ a b c Heithecker R, Aedo AR, Landgren BM, Cekan SZ (1991). "Plasma estriol levels after intramuscular injection of estriol and two of its esters". Hormone Research. 35 (6): 234–238. doi:10.1159/000181911. PMID 1819548.